KOREAN Air has been recertified by IATA's Centre of Excellence for Independent Validators Pharma (CEIV Pharma) for air transport of pharmaceuticals, reports London's Air Cargo News.
Korean Air provides customised cold chain services for a wide array of products that call for dynamic requirements and conditions. The airline transports pharmaceuticals such as vaccines, lab reagents and serums, and fresh products including flowers, fruits, seafood, through its "Specialised-Pharma" and "Specialised-Fresh" services.
Through a joint investment with Incheon International Airport Corporation, the airline operates a "Cool Cargo Centre" at the airport's Terminal 2.
Constructed in September 2021, the facility minimises exposure to adverse environments and reduces unnecessary movement and traffic.
The customised special cargo services facilitated the transport of emergency quarantine supplies over the course of the pandemic. More than one hundred million doses of vaccines have been shipped to date, and the airline continues to transport emergency medical supplies including Covid treatments and diagnostic kits, around the world.
Valid for three years, IATA certification requires a demanding evaluation of the airline's capabilities. After the initial certification in 2019, Korean Air formed a task force in February this year in preparation for recertification. Korean Air is currently considering a move for the new widebody freighters launched by Airbus and Boeing in recent months.
Need a China Shipping Agent to help you consolidate and ship internationally from China?
